Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface

Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this techniq...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of vascular surgery 2010-11, Vol.24 (8), p.1005-1014
Hauptverfasser: Zanow, Juergen, Kruger, Ulf, Settmacher, Utz, Scholz, Hans
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1014
container_issue 8
container_start_page 1005
container_title Annals of vascular surgery
container_volume 24
creator Zanow, Juergen
Kruger, Ulf
Settmacher, Utz
Scholz, Hans
description Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.
doi_str_mv 10.1016/j.avsg.2010.03.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_762029815</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0890509610001822</els_id><sourcerecordid>762029815</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</originalsourceid><addsrcrecordid>eNp9kU1rFTEUhoMo9lr9Ay4kO1dzPcl8JSCClLYKhRZuXYdMcuY215nJNckUZ-dPN8OtLly4Cpy8z0vyHELeMtgyYM2Hw1Y_xv2WQx5Auc2jZ2TDGlYXtaza52QDQkJRg2zOyKsYDwCMi0q8JGccBEDF5Yb8ug-o04hTor6ndxjcPug-0R0GP2rqJnr586gni5be-WFJmPL1MPvgMT0sA05Ir1cg0m7J0I85Nzk90CvXhQzvUA9u2q_d6QHp7ZwwnAC6m0OvDb4mL3o9RHzzdJ6Tb1eX9xdfipvb668Xn28KU7VNKrAta1tKUTadZVVlGlHXgnPei74pjYXWSqik5kIAgjUgula2He87aUuNLZbn5P2p9xh8fmVManTR4DDoCf0cVdtw4FKwOif5KWmCjzFgr47BjTosioFaxauDWsWrVbyCUuVRht491c_diPYv8sd0Dnw8BTB_8tFhUNE4nAxaF9AkZb37f_-nf3CTxTqjh--4YDz4OUxZn2IqcgVqt65-3TyDvPUsqvwNmsmqwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>762029815</pqid></control><display><type>article</type><title>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zanow, Juergen ; Kruger, Ulf ; Settmacher, Utz ; Scholz, Hans</creator><creatorcontrib>Zanow, Juergen ; Kruger, Ulf ; Settmacher, Utz ; Scholz, Hans</creatorcontrib><description>Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.</description><identifier>ISSN: 0890-5096</identifier><identifier>EISSN: 1615-5947</identifier><identifier>DOI: 10.1016/j.avsg.2010.03.016</identifier><identifier>PMID: 20800429</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Blood Vessel Prosthesis ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - instrumentation ; Chi-Square Distribution ; Device Removal ; Female ; Fibrin Tissue Adhesive - chemistry ; Fibrin Tissue Adhesive - therapeutic use ; Germany ; Humans ; Hydrophobic and Hydrophilic Interactions ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Polytetrafluoroethylene - chemistry ; Porosity ; Prosthesis Design ; Reoperation ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Seroma - etiology ; Seroma - surgery ; Surgery ; Time Factors ; Treatment Outcome ; Vascular Patency</subject><ispartof>Annals of vascular surgery, 2010-11, Vol.24 (8), p.1005-1014</ispartof><rights>Annals of Vascular Surgery Inc.</rights><rights>2010 Annals of Vascular Surgery Inc.</rights><rights>Copyright © 2010 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</citedby><cites>FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.avsg.2010.03.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20800429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zanow, Juergen</creatorcontrib><creatorcontrib>Kruger, Ulf</creatorcontrib><creatorcontrib>Settmacher, Utz</creatorcontrib><creatorcontrib>Scholz, Hans</creatorcontrib><title>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</title><title>Annals of vascular surgery</title><addtitle>Ann Vasc Surg</addtitle><description>Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Blood Vessel Prosthesis</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - instrumentation</subject><subject>Chi-Square Distribution</subject><subject>Device Removal</subject><subject>Female</subject><subject>Fibrin Tissue Adhesive - chemistry</subject><subject>Fibrin Tissue Adhesive - therapeutic use</subject><subject>Germany</subject><subject>Humans</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Polytetrafluoroethylene - chemistry</subject><subject>Porosity</subject><subject>Prosthesis Design</subject><subject>Reoperation</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Seroma - etiology</subject><subject>Seroma - surgery</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Vascular Patency</subject><issn>0890-5096</issn><issn>1615-5947</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1rFTEUhoMo9lr9Ay4kO1dzPcl8JSCClLYKhRZuXYdMcuY215nJNckUZ-dPN8OtLly4Cpy8z0vyHELeMtgyYM2Hw1Y_xv2WQx5Auc2jZ2TDGlYXtaza52QDQkJRg2zOyKsYDwCMi0q8JGccBEDF5Yb8ug-o04hTor6ndxjcPug-0R0GP2rqJnr586gni5be-WFJmPL1MPvgMT0sA05Ir1cg0m7J0I85Nzk90CvXhQzvUA9u2q_d6QHp7ZwwnAC6m0OvDb4mL3o9RHzzdJ6Tb1eX9xdfipvb668Xn28KU7VNKrAta1tKUTadZVVlGlHXgnPei74pjYXWSqik5kIAgjUgula2He87aUuNLZbn5P2p9xh8fmVManTR4DDoCf0cVdtw4FKwOif5KWmCjzFgr47BjTosioFaxauDWsWrVbyCUuVRht491c_diPYv8sd0Dnw8BTB_8tFhUNE4nAxaF9AkZb37f_-nf3CTxTqjh--4YDz4OUxZn2IqcgVqt65-3TyDvPUsqvwNmsmqwA</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Zanow, Juergen</creator><creator>Kruger, Ulf</creator><creator>Settmacher, Utz</creator><creator>Scholz, Hans</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101101</creationdate><title>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</title><author>Zanow, Juergen ; Kruger, Ulf ; Settmacher, Utz ; Scholz, Hans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-e735d39836bd144c68558222f8f63cd07d9049a2880e0dc08b797b2fb9d3ae7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Blood Vessel Prosthesis</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - instrumentation</topic><topic>Chi-Square Distribution</topic><topic>Device Removal</topic><topic>Female</topic><topic>Fibrin Tissue Adhesive - chemistry</topic><topic>Fibrin Tissue Adhesive - therapeutic use</topic><topic>Germany</topic><topic>Humans</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Polytetrafluoroethylene - chemistry</topic><topic>Porosity</topic><topic>Prosthesis Design</topic><topic>Reoperation</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Seroma - etiology</topic><topic>Seroma - surgery</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Vascular Patency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zanow, Juergen</creatorcontrib><creatorcontrib>Kruger, Ulf</creatorcontrib><creatorcontrib>Settmacher, Utz</creatorcontrib><creatorcontrib>Scholz, Hans</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zanow, Juergen</au><au>Kruger, Ulf</au><au>Settmacher, Utz</au><au>Scholz, Hans</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface</atitle><jtitle>Annals of vascular surgery</jtitle><addtitle>Ann Vasc Surg</addtitle><date>2010-11-01</date><risdate>2010</risdate><volume>24</volume><issue>8</issue><spage>1005</spage><epage>1014</epage><pages>1005-1014</pages><issn>0890-5096</issn><eissn>1615-5947</eissn><abstract>Background The recommended standard for treatment of perigraft seroma (PS) is the graft removal and the reconstruction using an alternative prosthesis. We assumed that a fibrin sealing of the outer surface of expanded polytetrafluoroethylene (ePTFE) grafts would prevent leakage and used this technique in the treatment and prevention of PS. Methods Over a 10-year period, 24 patients were treated for PS after subcutaneous implantation of ePTFE grafts (14 arterial bypasses and 10 arteriovenous grafts). Affected graft segments were temporarily removed and underwent sequential fibrin sealing technique before reimplantation. In addition, an in vitro experiment was carried out to demonstrate the efficacy of fibrin sealing to prevent leakage through the ePTFE graft wall, after its hydrophobic barrier was destroyed by filling with saline solution under pressure. Results A cure of PS was observed in 20 patients (84%) at a follow-up period of 37 ± 18 months. A later graft infection was not seen in any patient. The patency rate of reconstructed grafts appears to be unaffected. In the performed experiment we have demonstrated an elimination of leakage through the graft wall by the fibrin sealing technique. Conclusions Sequential fibrin sealing of the outer surface is an effective way to treat PS in ePTFE grafts. However, failure of this treatment cannot be precluded. Further studies are necessary that may provide further insights into the causes and best treatment of PS and the possibly important role of PS in the aneurysm enlargement after complete endovascular exclusion with ePTFE endografts.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>20800429</pmid><doi>10.1016/j.avsg.2010.03.016</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0890-5096
ispartof Annals of vascular surgery, 2010-11, Vol.24 (8), p.1005-1014
issn 0890-5096
1615-5947
language eng
recordid cdi_proquest_miscellaneous_762029815
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
Aged, 80 and over
Blood Vessel Prosthesis
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - instrumentation
Chi-Square Distribution
Device Removal
Female
Fibrin Tissue Adhesive - chemistry
Fibrin Tissue Adhesive - therapeutic use
Germany
Humans
Hydrophobic and Hydrophilic Interactions
Kaplan-Meier Estimate
Male
Middle Aged
Polytetrafluoroethylene - chemistry
Porosity
Prosthesis Design
Reoperation
Retrospective Studies
Risk Assessment
Risk Factors
Seroma - etiology
Seroma - surgery
Surgery
Time Factors
Treatment Outcome
Vascular Patency
title Treatment of Perigraft Seroma in Expanded Polytetrafluoroethylene Grafts by Sequential Fibrin Sealing of the Outer Graft Surface
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A46%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Perigraft%20Seroma%20in%20Expanded%20Polytetrafluoroethylene%20Grafts%20by%20Sequential%20Fibrin%20Sealing%20of%20the%20Outer%20Graft%20Surface&rft.jtitle=Annals%20of%20vascular%20surgery&rft.au=Zanow,%20Juergen&rft.date=2010-11-01&rft.volume=24&rft.issue=8&rft.spage=1005&rft.epage=1014&rft.pages=1005-1014&rft.issn=0890-5096&rft.eissn=1615-5947&rft_id=info:doi/10.1016/j.avsg.2010.03.016&rft_dat=%3Cproquest_cross%3E762029815%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=762029815&rft_id=info:pmid/20800429&rft_els_id=1_s2_0_S0890509610001822&rfr_iscdi=true